We found that mature IL-1β levels in atrial tissue were reduced in WT-CKD mice treated with anti–IL-1β antibody compared with WT-CKD mice given the IgG placebo (Figure 7, F and G). The gene discussed is IL1B; the disease is chronic kidney disease.